HEALTHJun 9 · 09:00 UTCNPR HEALTHYuki Noguchi

GLP-1s appear to protect against cancer. Researchers are trying to figure out how

Recent studies suggest GLP-1s, the weight loss and diabetes drugs, may prevent cancer and slow its progression by acting on brain and metabolic pathways beyond weight loss.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GLP-1stopicweight losstopicdiabetestopiccancertopicbrain pathwaystopicmetabolic pathwaystopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 9 · 09:00 UTC
GLP-1s appear to protect against cancer. Researchers are trying to figure out how
HEALTHMay 21 · 21:02 UTC
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
HEALTHMay 28 · 15:03 UTC
GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
HEALTHJun 6 · 13:28 UTC
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk